Package 69097-971-05

Brand: lisinopril and hydrochlorothiazide

Generic: lisinopril and hydrochlorothiazide tablets
NDC Package

Package Facts

Identity

Package NDC 69097-971-05
Digits Only 6909797105
Product NDC 69097-971
Description

90 TABLET in 1 BOTTLE (69097-971-05)

Marketing

Marketing Status
Marketed Since 2019-12-26
Brand lisinopril and hydrochlorothiazide
Generic lisinopril and hydrochlorothiazide tablets
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2815b0ef-9835-4b49-b98d-8519e7005dc1", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0369097971076", "0369097969073", "0369097968076"], "unii": ["0J48LPH2TH", "E7199S1YWR"], "rxcui": ["197885", "197886", "197887"], "spl_set_id": ["40e6b627-63dc-4d52-aaa8-750663ad86c2"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (69097-971-05)", "package_ndc": "69097-971-05", "marketing_start_date": "20191226"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (69097-971-07)", "package_ndc": "69097-971-07", "marketing_start_date": "20191226"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69097-971-12)", "package_ndc": "69097-971-12", "marketing_start_date": "20191226"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (69097-971-15)", "package_ndc": "69097-971-15", "marketing_start_date": "20191226"}], "brand_name": "Lisinopril and Hydrochlorothiazide", "product_id": "69097-971_2815b0ef-9835-4b49-b98d-8519e7005dc1", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "69097-971", "generic_name": "Lisinopril and Hydrochlorothiazide Tablets", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisinopril and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "LISINOPRIL", "strength": "20 mg/1"}], "application_number": "ANDA204058", "marketing_category": "ANDA", "marketing_start_date": "20191226", "listing_expiration_date": "20261231"}